Bodal Chemicals Q4 FY25 earnings call: Revenue & Margins
Q4 FY25 earnings call: what management said on revenue, margins and capex.
- Revenue
- ₹451Cr
- +14.5% YoY
- +1.8% QoQ
- Net profit
- ₹14Cr
- +600% YoY
- +180% QoQ
- Margin
- 10%
- +4 pp YoY
- 0 pp QoQ
Guidance rank: #34 of 70 in Chemicals & Petrochemicals
See the sector's top 10 — free with your mobile number.
The short version
FY'26 revenue is targeted at Rs. 1,900 crores plus, representing about 10% growth over FY'25. FY'26 top-line expected around Rs. 1,900 - 2,000 crores, approx. 10% growth from FY'25.
From Bodal Chemicals Ltd's Q4 FY25 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- FY'26 revenue is targeted at Rs. 1,900 crores plus, representing about 10% growth over FY'25.
- EBITDA margins expected at 11%-12% in FY'26, improving from FY'25 Q4 levels.
- Dye intermediate volumes to remain flat in FY'26 and FY'27, having achieved over 70% utilization.
- Dyestuff volumes projected to grow 10%-15% in FY'26 supported by better end-user demand.
- Benzene derivatives segment aims to increase utilization from ~30% to 60%-70% in FY'26, targeting 80% long-term.
- Caustic soda division expects 5%-10% volume growth in FY'26 with strong margins.
- Basic chemicals volume and revenue expected to remain stable, similar to FY'25.
2 more points from Bodal Chemicals Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Bodal Chemicals Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- No major CAPEX planned for FY'26; focus is on increasing utilization and reducing losses (especially in benzene derivatives).
- Small expansion possible at Rajpura caustic chlorine unit with low CAPEX, planned anytime as a brownfield project.
- Large-sized investments or expansions likely from FY'27 onwards or later, after improving debt-equity ratios and stabilizing businesses.
- FY'27 could see sizable CAPEX after achieving 15-20% growth and stabilizing newer opportunities.
2 more points from Bodal Chemicals Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Bodal Chemicals Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points from Bodal Chemicals Ltd's call on order book
Create a free account to keep reading this call
Bodal Chemicals Ltd — Quarterly revenue & net profit
Bodal Chemicals Ltd Q4 FY25 results — key figures
| ₹ Cr | Q4 FY25 | Q4 FY24 | YoY | Q3 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue | 451 | 394 | +14.5% | 443 | +1.8% |
| Operating profit (EBITDA) | 47 | 25 | +88% | 44 | +6.8% |
| Operating margin | 10% | 6% | +4 pp | 10% | 0 pp |
| Profit before tax | 12 | -2 | — | 8 | +50% |
| Net profit (PAT) | 14 | 2 | +600% | 5 | +180% |
| EPS (₹) | 1.15 | 0.16 | +618.7% | 0.43 | +167.4% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹863 Cr, net profit ₹81 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Bodal Chemicals's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Atul (Q4 FY25)
Consolidated revenue from operations for 2024-25: ₹5,583 cr, 18% increase YoY from ₹4,726 cr in 2023-24 (Page 36). Key concall takeaways from Atul Ltd's Q4…
- Vidhi Specialty (Q4 FY25)
109.5 Crs, up 40.2% YoY (from Rs. Key concall takeaways from Vidhi Specialty Food Ingredients Ltd's Q4 FY25 earnings call — and how it ranks against sector…
- Chemcon Speciality Chemicals (Q4 FY25)
54.9 Crs, down 8% YoY from Rs. Key concall takeaways from Chemcon Speciality Chemicals Ltd's Q4 FY25 earnings call — and how it ranks against sector peers.
- Valiant Organics (Q4 FY25)
Q4-FY25 revenue from operations (consolidated) was INR 2,038 million, a 15.3% year-on-year (YoY) increase from INR 1,768 million in Q4-FY24 (Page 12 and 10)…
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Bodal Chemicals Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Bodal Chemicals Ltd Q4 FY25 results?
FY'26 revenue is targeted at Rs. 1,900 crores plus, representing about 10% growth over FY'25. FY'26 top-line expected around Rs. 1,900 - 2,000 crores, approx. 10% growth from FY'25.
What is Bodal Chemicals Ltd share price analysis?
Bodal Chemicals Ltd currently shows a neutral. The stock trades at a P/E of 13.8 with a market cap of ₹950 Cr. Investors should review the full earnings analysis for detailed insights.
Is Bodal Chemicals Ltd planning capital expenditure?
No major CAPEX planned for FY'26; focus is on increasing utilization and reducing losses (especially in benzene derivatives).
Keep Bodal Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
